Korean journal of clinical oncology最新文献

{"title":"Risk factor for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma.","authors":"Ha Rim Ahn,&nbsp;Sang Yull Kang,&nbsp;Hyun Jo Youn,&nbsp;Sung Hoo Jung","doi":"10.14216/kjco.20006","DOIUrl":"https://doi.org/10.14216/kjco.20006","url":null,"abstract":"<p><strong>Purpose: </strong>The extent of surgery necessary in patients with unilateral papillary thyroid carcinoma (PTC) on preoperative radiologic imaging is still in doubt. In this study, we aimed to define risk factors that could be indicators for malignant nodules in the contralateral thyroid lobe.</p><p><strong>Methods: </strong>We included 438 patients who underwent total thyroidectomy between January 2011 and December 2014 at our institution. In this study, patients were divided into two groups according to the presence of contralateral occult carcinoma identified by postoperative pathological examination. We analyzed the clinicopathologic factors including characteristics of coexistent nodules in the contralateral lobe based on preoperative radiological imaging.</p><p><strong>Results: </strong>A total of 96 patients (21.9%) had PTC in the contralateral lobe. There were no significant differences between patients with or without contralateral occult carcinoma with respect to gender, age, primary tumor size, central lymph node metastasis, extrathyroidal extension and stage. The presence of Hashimoto's thyroiditis was an independent predictive factor for contralateral occult carcinoma (P=0.01).</p><p><strong>Conclusion: </strong>A risk factor for contralateral occult carcinoma in unilateral PTC patients is Hashimoto's thyroiditis. Therefore, more caution is needed when determining optimal surgical methods for PTC patients with Hashimoto's thyroiditis.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"33-38"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/1b/kjco-16-1-33.PMC9942722.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of clinical outcomes between sentinel lymph node biopsy and axillary lymph node dissection in a single-center Z0011-eligible breast cancer cohort.","authors":"Heein Jo,&nbsp;Eun-Gyeong Lee,&nbsp;Eunjin Song,&nbsp;Jai Hong Han,&nbsp;So-Youn Jung,&nbsp;Han-Sung Kang,&nbsp;Eun Sook Lee,&nbsp;Seeyoun Lee","doi":"10.14216/kjco.20004","DOIUrl":"https://doi.org/10.14216/kjco.20004","url":null,"abstract":"<p><strong>Purpose: </strong>The ACOSOG Z0011 trial has proven the oncological safety of sentinel lymph node biopsy (SLBx) for node negative breast cancer. Accordingly, treatment paradigm including axilla surgery was changed. We retrospectively reviewed breast cancer patients to evaluate the clinical effect of paradigm shift in breast cancer surgery after applying the Z0011 criteria.</p><p><strong>Methods: </strong>All women who underwent breast-conserving surgery at the National Cancer Center between January 1, 2000, and December 31, 2015, were enrolled and classified according to the Z0011 criteria. The primary endpoint of the study was the disease-free survival rates, and the secondary was the adverse events, especially arm lymphedema.</p><p><strong>Results: </strong>Total 361 patients were enrolled the study (271 axillary lymph node dissection [ALND] group, 90 SLBx group). After the Z0011 guideline was adopted in our institute, the use of ALND decreased, and lymph node sampling (removing only a few axillary lymph nodes) replaced ALND. The total mean number of retrieved nodes were more in ALND group (13.02) than SLBx group (3.43). However, there was no difference in the mean number of positive nodes between two groups (2.34 in ALND group vs. 1.12 in SLBx group, P=0.001). During follow-up, 25 patients experienced disease recurrence: 22 from the ALND group and three from the SLBx group. All of died seven patients were from the ALND group. The ALND group had more complications than the SLBx group (P=0.02). Arm edema occurred more frequently in the ALND group (29.5%) than in the SLBx group (5.6%), although without statistical significance (P=0.07).</p><p><strong>Conclusion: </strong>In our study, we concluded that SLBx can be used safely in Z0011-eligible cohort without increased risk of locoregional recurrence. Moreover, we found that omission of ALND is favored to reduce some serious complications such as arm lymphedema.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"18-24"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5e/22/kjco-16-1-18.PMC9942717.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9169779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparing the initiation of adjuvant chemotherapy after robotic and laparoscopic colon cancer surgeries: A case-controlled study with propensity score matching.","authors":"Sanghoon Kim,&nbsp;Sung Uk Bae,&nbsp;Seong Kyu Baek,&nbsp;Woon Kyung Jeong","doi":"10.14216/kjco.20003","DOIUrl":"https://doi.org/10.14216/kjco.20003","url":null,"abstract":"<p><strong>Purpose: </strong>Early initiation of adjuvant chemotherapy after colon cancer surgery has shown better oncologic outcomes in previous studies. However, the clinical impact of robotic and laparoscopic surgeries on the initiation of adjuvant chemotherapy has not been widely evaluated. Hence, the study's aim was to compare the influence of both surgical approaches on the initiation of adjuvant chemotherapy after colon cancer surgery.</p><p><strong>Methods: </strong>From June 2011 to September 2017, 289 patients underwent curative robotic or laparoscopic surgery followed by adjuvant chemotherapy for stage II and III colon cancer. To control for different demographic factors in the two groups, propensity score case matching was used at a 1:4 ratio. Finally, 190 patients were matched with 38 patients of the robotic surgery group and 152 patients of the laparoscopic surgery group.</p><p><strong>Results: </strong>The operation time was longer in the robotic surgery group (297 minutes vs. 170 minutes, respectively; P<0.001). However, conversion rate, number of retrieved lymph nodes, first flatus, first soft diet, length of stay, postoperative complication rate, and Clavien-Dindo grade were not significantly different between the two groups. Additionally, there was no difference in the time to initiation of adjuvant chemotherapy between the two groups (31.5 days vs. 29.0 days, respectively; P=0.226). Disease-free and overall survival rates were also not significantly different.</p><p><strong>Conclusion: </strong>Robotic and laparoscopic surgeries showed no different impact on the initiation of adjuvant chemotherapy. This finding suggests that the two surgical approaches offer similar postoperative outcomes.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"9-17"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6c/9b/kjco-16-1-9.PMC9942714.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9169777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk of osteoporosis and fracture in long-term breast cancer survivors.","authors":"Jieon Go,&nbsp;Suyeon Park,&nbsp;Kyeong Sik Kim,&nbsp;Min Chang Kang,&nbsp;Myong Hoon Ihn,&nbsp;Sangchul Yun,&nbsp;Sang Hyun Kim,&nbsp;Sung Hoon Hong,&nbsp;Jong Eun Lee,&nbsp;Sun Wook Han,&nbsp;Sung Yong Kim,&nbsp;Zisun Kim,&nbsp;Sung Mo Hur,&nbsp;Jihyoun Lee","doi":"10.14216/kjco.20007","DOIUrl":"https://doi.org/10.14216/kjco.20007","url":null,"abstract":"<p><strong>Purpose: </strong>High incidence of osteoporosis has been reported in breast cancer patients due to early menopause triggered by adjuvant treatment and temporary ovarian function suppression. In this study, we sought to determine whether long-term breast cancer survivors had an elevated risk of low bone density compared to the general population.</p><p><strong>Methods: </strong>Long-term breast cancer survivors who had been treated for more than 5 years were selected for this study. Data were obtained from medical records and using a questionnaire from the Korea National Health and Nutrition Examination Survey (KNHANES). An age-matched non-cancer control group was selected from the KNHANES records. Incidence of fracture and bone mineral density (BMD) were compared between the two groups.</p><p><strong>Results: </strong>In total, 74 long-term breast cancer survivors and 296 non-cancer controls were evaluated. The incidence of fracture did not differ between the two groups (P=0.130). No differences were detected in lumbar BMD (P=0.051) following adjustment for body mass index, while hip BMD was significantly lower in breast cancer survivors (P=0.028). Chemotherapy and endocrine treatment were not related to low BMD in breast cancer survivors. In more than half of the survivors, the 10-year risk of osteoporotic fracture was less than 1%.</p><p><strong>Conclusion: </strong>Long-term breast cancer survivors had low bone density but a comparable risk of fracture compared to non-cancer age-matched controls. Further studies on the factors related to low bone density in long-term breast cancer survivors are required.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/62/ca/kjco-16-1-39.PMC9942721.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Uncut Roux-en-Y gastrojejunostomy after totally laparoscopic distal gastrectomy: Learning curve and surgical outcomes.","authors":"Amy Kim,&nbsp;Moon-Won Yoo","doi":"10.14216/kjco.20008","DOIUrl":"https://doi.org/10.14216/kjco.20008","url":null,"abstract":"<p><strong>Purpose: </strong>Totally laparoscopic distal gastrectomy (TLDG) is now widely used for early gastric cancer patients, but the selection of a reconstruction method after TLDG is still controversial. Roux-en-Y gastrojejunostomy is increasingly used in expectation of less gastritis and alkaline reflux despite its technical difficulty. The uncut Roux-en-Y gastrojejunostomy (uRYGJ) retains the advantages of Roux-en-Y reconstruction but helps prevent Roux stasis syndrome. The present study aims to introduce a single surgeon's experience of TLDG with uRYGJ and analyze the learning curve and surgical outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed the medical records of 124 consecutive patients who underwent TLDG with uRYGJ performed by a single surgeon between July 2014 and August 2015 at Asan Medical Center. The baseline characteristics and surgical outcomes were analyzed, and the learning curve was drawn based on the power-law model.</p><p><strong>Results: </strong>The mean total operative time was 165 minutes, and the average length of hospital stay was 6.6 days. Complications included two cases of duodenal stump leakage, two intra-abdominal bleeding, two intra-abdominal fluid collection, one wound problem, two anastomotic strictures, 14 ileus, and no anastomotic leakage. There were five cases of endoscopically proven reflux gastritis/esophagitis and no Roux stasis syndrome. There were five recurrences and one mortality during the follow-up period. The learning curve leveled at the 15th case.</p><p><strong>Conclusion: </strong>The results of our study showed the safety and feasibility of uRYGJ, and that the technical difficulty of the procedure can be overcome with a short learning curve for experienced surgeons.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"46-51"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/f6/kjco-16-1-46.PMC9942719.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Poorly differentiated thyroid carcinoma: An institutional experience.","authors":"Seok Won Choi,&nbsp;Joon-Hyop Lee,&nbsp;Yun Young Kim,&nbsp;Yoo Seung Chung,&nbsp;Sangtae Choi,&nbsp;Na Rae Kim,&nbsp;Jin Mo Kang,&nbsp;Heung Kyu Park,&nbsp;Yong Soon Chun","doi":"10.14216/kjco.20005","DOIUrl":"https://doi.org/10.14216/kjco.20005","url":null,"abstract":"<p><strong>Purpose: </strong>The incidence of poorly differentiated thyroid carcinoma (PDTC) is extremely low among thyroid cancers and there is no standardized treatment guideline for it. In this study, we have analyzed PDTC patients and reviewed their clinicopathological features.</p><p><strong>Methods: </strong>Data of PDTC patients from our institution are collected through the electronic medical database. We analyzed them by several parameters such as basic demographics, presenting symptom, preoperative cytology results, associated pathology, surgical results, surgery type, and distant metastasis.</p><p><strong>Results: </strong>We collected 23 cases in our institution. Apart from two patients who were transferred to another hospital upon diagnosis, all 21 operated cases are analyzed. The parameters we studied were age, sex, presenting symptoms, distant metastasis and pathological features such as tumor size, associated pathology, predominant pattern and so on. We also provided descriptive analyses according to the type of presentation and treatment; patients with distant metastasis, juvenile cancer, and concurrent hyperthyroidism. Furthermore, we provided different cases in which the initial surgical plans differed.</p><p><strong>Conclusion: </strong>We present 21 cases of PDTC patients and clarify their clinicopathological features. Despite some limitations, this study may shed light for future research regarding treatment of PDTC patients.</p>","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"16 1","pages":"25-32"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/11/kjco-16-1-25.PMC9942713.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9215095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognosis of proximal upper-third gastric cancer excluding tumors originating in the esophagogastric junction","authors":"Joong Ho Lee, Y. Hong, Y. Choi, Hyunsun Lim, Sangheon Lee","doi":"10.14216/kjco.19017","DOIUrl":"https://doi.org/10.14216/kjco.19017","url":null,"abstract":"The frequency of gastric cancer detected in the proximal upper-third of the stomach has increased in both the Eastern and Western hemispheres [1,2]. Existing evidence suggests that the anatomical location of stomach tumors may influence the recurrence of gastric cancer after treatment. Currently, cancer originating in the esophagogastric junction (EGJ) and the cardia exhibit different lymphatic drainage than distal gastric cancer [3], leading to worse prognoses compared to tumors located in other areas of the stomach [4,5]. Excepting tumors of EGJ origin, the prognosis of gastric cancer detected in the proximal upper-third of the stomach has not been established. Several studies have investigated primary tumor location and association with gastric cancer prognosis. The results of these prior studies have been contradictory, however, with some reporting a poorer prognosis in patients with a tumor in the proximal upper-third of the stomach compared with that in the distal region [6,7], whereas other studies have indicated no relationship between prognosis and the longitudinal location of the tumor in the stomach [8]. To date, no studies have reported a definitive prognosis of proximal upper-third gastric cancer excepting cancer of the EGJ. Accordingly, the focus of the current study was on the prognosis and clinicopathological outcomes of adenocarcinoma of the proxOriginal Article Korean Journal of Clinical Oncology 2019;15:93-99 https://doi.org/10.14216/kjco.19017 pISSN 1738-8082 ∙ eISSN 2288-4084","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"12 1","pages":"93-99"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84224310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patterns of antibiotics and pathogens for anastomotic leakage after colorectal cancer surgery","authors":"G. Yang, Chang Woo Kim, Suk-Hwan Lee","doi":"10.14216/kjco.19015","DOIUrl":"https://doi.org/10.14216/kjco.19015","url":null,"abstract":"Intra-abdominal infection (IAI) represents a wide variety of pathological conditions that can involve lesions of all the intra-abdominal organs. It should be treated with appropriate antibiotic therapy with proper interventions for source control. Choice of appropriate antibiotic must be based on the results of the culture study; the strain that caused the infection, profile of bacteria, and resistance to antibiotics. However, because the results usually require a few days, empirical antibiotics should be administered first, and then, the extension of the administration or the replacement of antibiotics can be considered depending on the results of the test [1]. Antibiotic resistance disables several mechanisms of antibiotics against bacteria, subsequently increases medical expense, as well as affects effectiveness of antibiotics against infection [2-4]. The Centers for Disease Control and Prevention has reported that the estimated minimum number of illnesses and deaths caused by antibiotics resistance were at least 2 million illness and 23,000 deaths each year in the United States [5]. In addition, guidelines already recommend appropriate antimicrobial agents on the basis of high-quality evidence and advise understanding of the microbiological profiles and resistance of the key pathogens causing IAI in Original Article Korean Journal of Clinical Oncology 2019;15:79-85 https://doi.org/10.14216/kjco.19015 pISSN 1738-8082 ∙ eISSN 2288-4084","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"185 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76421628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A cavernous hemangioma located in the axillary area: Challenges in preoperative diagnosis and operation","authors":"Jihye Choi, Chan Sub Park, Joonseog Kong, Hyun-Ah Kim, W. Noh, M. Seong","doi":"10.14216/kjco.19022","DOIUrl":"https://doi.org/10.14216/kjco.19022","url":null,"abstract":"Axillary cavernous hemangiomas are extremely rare benign neoplasms, with only two cases reported in the English literature to date. In the first case, in 1982, a 22-year-old Caucasian woman presented with a large tender mass in the left axilla [1]. Although its exact size was not mentioned, the mass filled the axilla and the lateral thoracic surface of the long thoracic nerve, invading the hemisphere of the left breast. Owing to massive bleeding, surgery was unsuccessful, and the remnant hemangioma was treated by using a carbon dioxide laser. In the second case, in 2008, a 43-year old Brazilian woman presented with an axillary mass and adjacent lymphadenomegaly, raising suspicion of a malignant breast neoplasm [2]. Core needle biopsy was contraindicated owing to the high vascularity of the mass and its proximity to the thoracic wall and axillary vessels. Excisional biopsy, however, was successful since the hemangioma was relatively small (3 cm). A salient point of the 2008 report was that axillary cavernous hemangiomas can mimic malignant cancers. Herein, we describe a surgically treated axillary cavernous hemangioma in a Korean woman and review the pertinent literature. The Institutional Review Board of the Korea Cancer Center Hospital approved the protocol version 1.0 (KIRAMS 2018-03-011).","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"6 1","pages":"127-131"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87480839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Total quilting suture at latissimus dorsi muscle donor site: Drain tube is no longer needed","authors":"Y. Cha, Seokwon Lee, Y. Bae, Y. Jung, J. Choi","doi":"10.14216/kjco.19021","DOIUrl":"https://doi.org/10.14216/kjco.19021","url":null,"abstract":"Latissimus dorsi myocutaneous flap (LDMCF) is one of the most frequently used autologous tissue flaps for breast reconstruction after partial or total mastectomy in patients with breast cancer. The most common postoperative complication in reconstructive surgery using LDMCF is seroma formation at the donor site. The incidence of seroma formation at the LDMCF donor site has been reported as high as approximately 70% to 80% [1-3]. Postoperatively, a seroma can cause patient discomfort and a longer period for maintaining the drain tube, which can lead to longer hospitalization. In addition, frequent needle aspiration of a seroma or outpatient visit may be required. A seroma can be a substantial cause of a patient’s discomfort, anxiety, infection, wound dehiscence, and consequently, flap necrosis, and scarring [4,5]. Consequently, postoperative adjuvant therapy including chemotherapy and radiation therapy may be delayed. Several studies have shown that use of the quilting suture technique at the LDMCF donor site helps reduce seroma formation and further complications after breast reconstruction surgery [6-12]. However, there has been no previous study about the effect regarding the extent of quilting suture at the LDMCF donor site. We investigated the degree of seroma formation and the need for a drainage tube according to the extent of quilting suturing at the LDMCF donor site.","PeriodicalId":74045,"journal":{"name":"Korean journal of clinical oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76385842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}